International Stem Cell Corp (ISCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,003 | -1,459 | -373 | -4,265 | -1,552 |
| Depreciation Amortization | 192 | 128 | 63 | 285 | 203 |
| Accounts receivable | 1,006 | 821 | 377 | -864 | -429 |
| Accounts payable and accrued liabilities | -263 | -75 | -120 | 196 | 264 |
| Other Working Capital | 591 | 537 | 171 | 128 | -18 |
| Other Operating Activity | 447 | 295 | 147 | 3,123 | 516 |
| Operating Cash Flow | $-30 | $247 | $265 | $-1,397 | $-1,016 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -24 | -22 | -3 | -164 | -146 |
| Purchase Sale Intangibles | -58 | -48 | -38 | -330 | -250 |
| Other Investing Activity | -58 | -48 | -38 | -330 | -250 |
| Investing Cash Flow | $-82 | $-70 | $-41 | $-494 | $-396 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 654 | 654 | 0 | 1,300 | 800 |
| Financing Cash Flow | $654 | $654 | $0 | $1,300 | $800 |
| Beginning Cash Position | 484 | 484 | 484 | 1,075 | 1,075 |
| End Cash Position | 1,026 | 1,315 | 708 | 484 | 463 |
| Net Cash Flow | $542 | $831 | $224 | $-591 | $-612 |
| Free Cash Flow | |||||
| Operating Cash Flow | -30 | 247 | 265 | -1,397 | -1,016 |
| Capital Expenditure | -24 | -22 | -3 | -164 | -146 |
| Free Cash Flow | -54 | 225 | 262 | -1,561 | -1,162 |